【摘要】 目的 探讨腹主动脉瘤腔内修复术（EVAR）的中远期治疗效果。方法 收集2006年8月至2020年3月大理白族自治州人民医院收治的170例行EVAR治疗的肾下型腹主动脉瘤患者的临床资料，对全部患者进行随访，并对患者的围手术期病死率、中远期并发症发生率和二次手术干预率等指标进行分析。结果 170例患者的随访率为80.0%。随访期间，全因死亡率为12.5%，生存率为87.5%。在有效随访的136例患者中，腹主动脉瘤相关病死率为1.5%。术后第13天，以及术后第3、12、24个月发生Ⅰ型内漏患者5例；术后第6个月发生Ⅱ型内漏患者1例；术后第3个月发生Ⅲ型内漏患者1例；术后第4天、第15天、第24个月发生支架内血栓形成患者3例；术后第3个月发生右髂动脉支架狭窄患者1例；术后第1个月发生支架移位患者1例。二次干预率为6.6%。结论 随着术后随访工作的进一步精细化、标准化、长期化，可以实现对EVAR后并发症的及早发现和及时干预，同时操作水平的提高能够提升中远期手术效果。更多还原

【Abstract】 Objective To investigate the mid-and long-term therapeutic effect of endovascular aneurysm repair(EVAR) of abdominal aortic aneurysm. Method A total of 170 patients undergoing EVAR of abdominal aortic aneurysm between August 2006 and March 2020 were followed up by Dali Bai Autonomous Prefecture People’s Hospital. Their perioperative mortality, mid-and long-term complication rates, secondary surgical intervention rates, and other indicators were analyzed. Result The follow-up rate was 80.0% among all 170 patients. During the follow-up, all-cause mortality was 12.5% and overall survival was 87.5%. Among 136 patients with effective follow-up, abdominal aortic aneurysmrelated mortality was 1.5%. On the 13th day, 3 months, 12 months, and 24 months after the surgery, 5 patients had type I endoleak; 1 patient had type II endoleak at 6 months after the surgery; 1 patient had type Ⅲ endoleak at 3 months after the surgery; 3 patients suffered stent thrombosis on the 4th day, 15th day, and 24 months after the surgery; 1 patient fell right iliac artery stent stenosis at 3 months after the surgery; 1 patient experienced stent displacement at 1 month after the surgery. The secondary intervention rate was 6.6%. Conclusion As the further refinement, standardization, and long-term follow-up is conducted, early detection and timely intervention of postoperative complications of EVAR could be realized.At the same time, the improvement of the surgery would also be a benefit to the mid-and long-term surgical effect.更多还原